Compumedics Limited (ASX:CMP)

Market Cap	43.95M -21.1%
Revenue (ttm)	58.49M +23.5%
Net Income	113.00K
EPS	0.00
Shares Out	199.76M
PE Ratio	388.92
Forward PE	14.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,250
Open	0.2300
Previous Close	0.2250
Day's Range	0.2200 - 0.2300
52-Week Range	0.2200 - 0.4500
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in the Americas, Australia, the Asia Pacific, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; and Somté, an investigative tool. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory stud...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 175
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CMP

Financial Performance

In fiscal year 2025, Compumedics's revenue was 51.04 million, an increase of 1.55% compared to the previous year's 50.26 million. Losses were -1.27 million, 275.1% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 17, 2026

Data Sources Report a data error